Background: Nutritional screening tools recommended for the general hospitalised population do not always adequately detect malnutrition risk in patients with kidney disease. The present study assessed the validity and reliability of the Nutrition Impact Symptoms (NIS) score as a nutrition screening tool for hospitalised inpatients prefer in nephrology wards. Methods: Nutritional status was classified using Subjective Global Assessment (SGA). NIS scores were calculated from the total score of responses to questions assessing symptoms impacting upon nutritional status from the patient-generated SGA. Concurrent validity of NIS score was assessed using a receiver operating characteristic curve to predict malnutrition risk against SGA. Predictive validity was examined against length of hospital stay (LOS) and 30-day re-admission using Poisson and logistic regression, respectively. Inter-rater reliability of NIS scoring between assessors was determined using intraclass correlation. Results: In 143 patients [90 males; mean (SD) age 57.8 (15.8) years], malnutrition prevalence was 38% (54/143) using SGA (rating B/C). Predicting malnutrition risk with an NIS score of ≥3 had a sensitivity of 0.89 and a specificity of 0.65 (area under the curve = 0.81 [95% confidence interval (CI) = 0.74-0.88]). For each 1-point increase in NIS score, the model predicted a 1.9% rise in the risk of an increased LOS (P = 0.002). Thirty-day re-admission was not associated with NIS score. Inter-rater reliability was moderate (mean difference = 0.53; intraclass correlation coefficient = 0.74; 95% CI = 0.57-0.85). Conclusions: Nutrition impact symptoms score is a valid stand-alone nutrition screening tool for identifying malnutrition risk in nephrology inpatients and is associated with LOS.
Introduction
Malnutrition is a common complication of renal disease, particularly in the later stages of chronic kidney disease (CKD). Studies demonstrate that over 50% of patients admitted to nephrology wards are malnourished (1, 2) , and uraemia, acidosis, dialysis and comorbidities all impact upon food intake and nutritional status in patients with kidney disease (3, 4) . Impaired nutritional status is associated with poor clinical outcomes, including increased morbidity, longer hospital stay, re-admission, reduced quality of life and poorer survival (5) (6) (7) (8) (9) . Nutrition screening is a simple and efficient method for identifying those at risk of malnutrition, and screening in the hospital setting helps ensure that patients receive timely and effective treatment where needed (10, 11) . In the UK, the Malnutrition Universal Screening Tool (MUST), identifies between 19%-60% of hospitalised patients as at risk of malnutrition (10) . However, evidence suggests that MUST lacks sensitivity and identifies only those at the highest malnutrition risk in patients with kidney disease compared to nutrition assessment with Subjective Global Assessment (SGA) (12) . Fluctuations in weight as a result of fluid retention masking undetected loss of tissue may make the detection or assessment of weight loss difficult, a factor that is essential for the accurate completion of MUST and any other tool using body mass index as a screening criterion (2) . Other nutrition screening tools such as the Mini Nutrition Assessment and Malnutrition Screening Tool (MST) have also demonstrated little promise for use in patients with kidney damage (2, 13) . These findings are in agreement with the results of a systematic review reporting no single screening tool is appropriate for use in all hospitalised patients, and that future research should focus on trying to identify the most suitable screening tools for specific patient groups (14) . Research on renal specific nutrition screening tools has continued. The renal nutrition screening tool (R-NST) was recently developed and tested for validity and feasibility (1) . The R-NST demonstrated high sensitivity and specificity against SGA; however, when introduced into clinical practice, there was low uptake when used by nurses, attributed to the need to access information from electronic clinical information systems, and poor agreement for scoring between researchers and nurses (1) . Therefore, the need for a user friendly and valid nutrition screening tool for renal patients remains evident.
The Nutrition Impact Symptoms (NIS) score (Table 1) is part of the patient-generated SGA (PG-SGA), a validated nutrition assessment tool initially developed for use in oncology and also validated in haemodialysis (15, 16) . Based on recent evidence supporting the efficacy of the NIS score as a nutrition screening tool for haemodialysis outpatients (17) , and the high level of malnutrition with multiple aetiologies in patients admitted to nephrology wards, it is hypothesised that the NIS score may be a valid and reliable nutrition screening tool for renal inpatients on nephrology wards.
Materials and methods
A cross-sectional and observational validation study was conducted. Patients over 18 years were considered eligible for inclusion in the present study if they were admitted for a planned or unplanned/emergency admission, under the care of a consultant nephrologist, to an acute renal unit consisting of two wards, and had been an inpatient for <4 days. Confidentiality was maintained by coding patient identifiable details on paper records and in secure password protected electronic documentation.
Concurrent validity
To calculate the NIS score, patients were asked 'Have you had any of the following problems that have kept you from eating enough during the past 2 weeks?', followed by listing each NIS symptom in turn. The total NIS score was calculated by adding the scores for all symptoms identified positively by patients (Table 1) . Individual NIS were only scored positively if they affected food intake (15) . The SGA was completed at the same time using the standard method (12) and SGA global classifications were used to categorise nutritional status (A, well nourished; B, moderately malnourished; C, severely malnourished). Patients identified as malnourished, with an SGA rating of B or C, were referred directly to the responsible clinical renal dietitian for further assessment and intervention. The ability of the NIS score to identify malnutrition risk was assessed against the SGA global classification of nutritional status as the reference standard. Specificity [true negative cases/(true negative + false positive) cases] and sensitivity [true positive cases/(true positive + false negative) cases] of a range of NIS scores to detect malnutrition risk were determined.
Predictive and clinical validity
Predictive validity was evaluated against length of stay (LOS) and re-admission to any ward in the same hospital within 30 days of discharge. LOS was defined as the total number of days spent as an inpatient during the admission, calculated by subtracting the hospital admission date from the date of discharge. Serum albumin and C-reactive protein (CRP) concentrations on admission were recorded for each patient and the Charlson Comorbidity Index score (18) was calculated using clinical history and demographic data from electronic patient records.
Inter-rater reliability
The reliability of the NIS score was determined by repeating the NIS score in a subgroup of study participants (n = 43) using a second measurer (a dietitian, nurse or healthcare assistant), who was blinded to the initial scoring, to assess NIS score only. The NIS score was repeated on the same day to ensure that conditions were comparable.
Statistical analysis
Statistical analysis was carried out using SPSS, version 22 (IBM Corp., Armonk, NY, USA). Sample size calculations were based on findings from pilot testing of the NIS tool. With an expected prevalence of malnutrition at 50%, 88% specificity and 80% sensitivity for NIS, and precision within 10% and type-1 error of 5%, 125 patients were required in the study. Normality of the data was assessed using histograms and the Shapiro-Wilk test of normality. P < 0.05 was considered statistically significant and 95% confidence intervals (CIs) were computed where applicable. Baseline characteristics between malnourished (SGA B or C) and well nourished (SGA A) patients were compared with chi-squared tests (or Fisher's exact test when needed) for categorical variables, as well as independent t-tests or a Mann-Whitney U-test for parametric and nonparametric continuous variables, respectively.
To establish the optimal NIS cut-off score maximising the sensitivity and specificity of the tool with respect to determining malnutrition risk, a receiver operating characteristic (ROC) curve and contingency table were produced comparing the NIS score with the SGA global rating of nutritional status as the reference standard (where SGA A = well-nourished and SGA B or C = malnourished). With the finalised risk categories, concurrent validity of the NIS score was examined against the SGA global rating of nutritional status to determine the sensitivity and specificity of the NIS score with respect to identifying malnutrition risk using the contingency table.
The associations between NIS score and clinical morbidity indicators, CRP, albumin and Charlson score, were assessed with Spearman rank correlations. The relationships between all four indicators and LOS or 30-day readmission were examined using Poisson linear regression analysis and forward, stepwise logistic regression analysis, respectively. Intraclass correlation tested the inter-rater reliability of the NIS score.
Results
Of the 178 potentially eligible patients, 143 patients were recruited to the study. Baseline characteristics are outlined in Table 2 . In total, 38% of patients were malnourished when classified by SGA (33% as SGA rating B and 5% classified as SGA rating C). Albumin, CRP and NIS score were significantly different between well-nourished and malnourished patients, and malnourished patients had a greater proportion of emergency/unplanned admissions, compared to those who were well nourished.
Concurrent validity
Examination of the contingency table indicated that the concurrent validity of the NIS score was greatest at a score of ≥3, classifying 55% (79/143) of patients as at risk of malnutrition. The area under the ROC curve was 0.81 (95% CI = 0.74-0.88), indicating good concurrent validity (14) . Sensitivity was 89% (true risk of malnutrition identified) and specificity was 65% (true no risk of malnutrition identified) compared to SGA.
Predictive and clinical validity
Using rank correlation, NIS score was associated with CRP (q = 0.22, P = 0.011) but not albumin or Charlson score. In the Poisson regression model, all factors predicted an increased risk of longer LOS; lower serum albumin concentration on admission, higher CRP, higher NIS score and lower Charlson score (Table 3) . For each 1-point increase in NIS score, the model predicted a 1.9% rise in the risk of an increased LOS (P = 0.002). Using the median NIS score of 7 for malnourished patients, the risk of a longer LOS increased by 13.3%. In total, 31 (22%) patients were readmitted to the same hospital within 30-days of discharge (five planned and 26 unplanned admissions). Factors associated with 30-day re-admission were initial unplanned admission, LOS and albumin (Table 4) . NIS score, Charlson score and CRP were not associated with re-admission to hospital within 30 days, and these results did not change when the analysis was limited to unplanned re-admissions only (data not shown).
Inter-rater reliability
There was no difference in the total NIS score between measurers in 37% of cases. The mean (SD) difference between repeated NIS scores was 0.53 (2.81). The intraclass correlation coefficient was 0.74 (95% CI = 0.57-0.85), indicating moderate reliability between users.
Discussion
The present study established that the NIS score is a valid nutrition screening tool for assessing malnutrition risk in patients admitted to nephrology wards. Concurrent, clinical and predictive validity were demonstrated by comparison with the SGA global rating of nutritional status, as well as by association with CRP and increased risk of longer LOS, respectively.
Compared with SGA, the concurrent validity was considered to be at its highest with an NIS score of ≥3. This NIS score cut-off is higher than that selected in a previous investigation involving 213 haemodialysis outpatients, which reported that a NIS score of ≥2 was most effective at detecting malnutrition risk (17) . Median NIS scores in the well-nourished and malnourished groups were 1.0 and 3.5 points lower, respectively, than the median scores in the present study, and less than one-quarter of patients were classified as malnourished, indicating that, when malnutrition risk is lower, the threshold for detection with a nutrition screening tool is also lower, aiming to maximise sensitivity. Together, these studies demonstrate the flexibility of the NIS score as a screening tool across different setting in patients with CKD, as well as the importance of validating nutrition screening tools within the intended patient population. A nutrition screening tool should have a high level of sensitivity to reduce the risk of failing to detect malnutrition risk in a malnourished patient (false negative result) (10) . A NIS score ≥3 had a sensitivity of 89%, demonstrating a far superior ability to detect malnutrition risk in patients with kidney disease than the MUST and MST tools, which were shown to have sensitivities of 54% and 49% compared to SGA, respectively (2) . With a specificity of 65%, the NIS score at a cut-off of ≥3 was relatively effective at identifying well-nourished patients, with similar specificity to the MST (19) , although it does carry a reasonably high rate of false positive results. More recently, another nutrition screening tool, the R-NST, was developed specifically for renal inpatients (1) . The R-NST is more complex than the NIS score, and includes biochemical parameters alongside nutrition impact symptoms and weight-loss history. The R-NST demonstrated high sensitivity (97%) and moderately high specificity (74.4%) compared to SGA. However, in the reliability and feasibility phase of the study, the R-NST tool had low levels of completion by clinical staff as a result of the time taken to calculate 6-month weight change and extract the clinical data from the electronic medical records. Reliability was difficult to measure because of the very low completion rate for nursing staff (1) . Together, these results indicate that the R-NST may have limited translational capacity for use in clinical practice.
This present study is the first investigation to show that the NIS score is associated with LOS, an indicator of morbidity in patients with kidney disease (20) , thus demonstrating a degree of predictive validity of the NIS score. The NIS score has also previously been shown to predict long-term clinical outcomes in patients on maintenance haemodialysis because an NIS score of ≥2 was associated with a higher risk of mortality, whereas the SGA global rating was not (17) . The NIS score had moderate inter-rater reliability, with an intraclass correlation coefficient of 0.74, and identical NIS scores were reported between assessors in 37% of patients. Although this is less than ideal, it is significantly higher than the agreement between assessors using the R-NST, where there same score was achieved in the repeated measure in only 8% of cases (1) . Reliability of nutritional assessment using SGA can also be limited, with only fair inter-rater reliability between assessors following completion of an online training package (21) . The research team provided brief training to clinical assessors before determining the NIS score. Between-user differences might be minimised by introducing more in-depth training for all assessors, where measurers would be expected to demonstrate competency before using the NIS score in practice.
The limitations of the present study are also acknowledged. In each assessment, the NIS and the SGA were undertaken by the same researcher in a single session and so blinding the researchers to the outcomes of the individual components was not possible. However, because the study was conducted in three different time periods with different researchers, the robustness of the tool across users and over time is demonstrated. There are several advantages of using the NIS score as a nutrition screening tool in preference to other tools. The NIS score does not require measurement of body weight, knowledge of oedema free weight or previous weight loss. The NIS score also has no biochemical parameters included and so it can be quickly and easily completed at the bedside. Furthermore, the NIS score can identify the main factors impacting on food intake early during hospitalisation and can thus inform subsequent interventions to improve nutritional status (17) . Because the NIS score identifies specific factors relating to malnutrition risk, it guides the choice of clinical intervention. Symptoms such as dry mouth, taste changes, nausea, vomiting and constipation can all be treated clinically, whereas swallowing problems, feeling full quickly and fatigue require specific nutritional interventions.
The outcomes of the present study support the use of the NIS score as a nutrition screening tool for hospitalised patients on nephrology wards, adding to previous findings supporting its use in haemodialysis outpatients. Concurrent, predictive and clinical validity were demonstrated, and the reliability between users was moderate. Future research into the use of the NIS as a nutrition screening tool should focus on the effect of training and nursing involvement in clinical implementation and also patient focused outcomes such as quality of life, and functional capacity at discharge.
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